The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis

NCT03483597 | Completed

• 1 other identifier: CRDC-satisfaction
• Study Type: observational
• Target: 1,365
• Locations: 1 country
• Sites: 1

Brief Summary

A questionnaire for this research is designed, which initiated from TSQM-II treatment satisfaction questionnaire and based on research launched by rheumatology and immunology departments of Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research is about treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for treating this disease. This research will explore the matching degree between treatment satisfaction and expectation about rheumatoid arthritis from doctors and patients.

Conditions

Rheumatoid Arthritis; Satisfaction

Outcome Measures

Primary Outcomes (1)

• Total score of patient satisfaction

  Total score of patient satisfaction

  1 day

Secondary Outcomes (7)

• Average score of patients for various treatment demands

  1 day

• Average score of patients for long-term treatment demands

  1 day

• Average score of patients for new drug demands

  1 day

• Total score of doctor satisfaction

  1 day

• Average score of doctors for various treatment demands

  1 day

Study Arms (2)

rheumatologists

Inclusion criteria: Registered rheumatoid specialist physicians subordinated to the 12 designated hospitals The Treatment Satisfaction Questionnaire for Medication (TSQM-II) will be used in rheumatologists.

Other: TSQM-II

patients

Inclusion criteria: Aged over 18, confirming RA for more than 6 months Exclusion criteria. Patients with Chinese reading comprehension barriers (unable to complete the questionnaire independently), without any RA treatment The Treatment Satisfaction Questionnaire for Medication (TSQM-II) will be used in patients.

Other: TSQM-II

Interventions

TSQM-II OTHER

Treatment Satisfaction Questionnaire for Medication (TSQM Version II) will be used in all groups

patients; rheumatologists

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Subjects come from 12 hospitals in Chinese Rheumatism Data Center.

You may qualify if:

• Doctors - registered rheumatoid specialist physicians subordinated to the 12 designated hospitals Patients - aged over 18, confirming RA for more than 6 months

You may not qualify if:

• Doctors - N/A Patients - with Chinese reading comprehension barriers (unable to complete the questionnaire independently), without any RA treatment

Sponsors & Collaborators

• Chinese SLE Treatment And Research Group: lead

Study Sites (1)

Peking Union Medical College Hospital

Beijing, 100730, China

Location

MeSH Terms

Conditions

Arthritis, Rheumatoid; Personal Satisfaction

Condition Hierarchy (Ancestors)

Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases; Behavior

Study Officials

• Xiaofeng Zeng, Doctor

  Director of Rheumatology and Immunology Department Chinese Academy of Medical Sciences &Peking Union Medical College Hospital

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 21, 2018
• First Posted: March 30, 2018
• Study Start: March 31, 2018
• Primary Completion: April 30, 2018
• Study Completion: April 30, 2018
• Last Updated: August 31, 2023

Record last verified: 2018-03

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)